Cutler Group’s Phibro Animal Health PAHC Stock Holding History

Cutler Group’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,200	Closed	-$1K	–	7187
2016 Q2	$1K	Buy	+1,200	New	+$25K	﹤0.01%	6187

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FIM

Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return

VFA

Virtus Fund Advisers Hartford, Connecticut $32.1M AUM 39.5% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CRCP

Copper Rock Capital Partners Boston, Massachusetts $296M AUM 28.61% 1-Year Est. Return

DIA

Denver Investment Advisors Denver, Colorado $1.89B AUM 7.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cutler Group's PAHC Position: Q3 2017 in Review

Cutler Group sold out of Phibro Animal Health (PAHC) in Q3 2017, closing a stake of 219 shares — an estimated $8K sold.

Cutler Group first reported a position in PAHC in Q4 2015 and held it in 7 quarters. The position peaked at $31K in Q4 2015. 164 funds tracked by Wall St. Rank hold PAHC as of Q3 2017.

Cutler Group reported no remaining Phibro Animal Health position as of Q3 2017 after selling out during the quarter.
Cutler Group sold 219 Phibro Animal Health shares in Q3 2017, an estimated $8K.
Cutler Group first reported a position in Phibro Animal Health in Q4 2015 and held it in 7 quarters.
Cutler Group's Phibro Animal Health position peaked at $31K in Q4 2015.
164 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2017.

Based on Cutler Group's 13F filing for Q3 2017, filed 17 Oct 2017.